SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to enthusiasm for its Merck-partnered personalized melanoma vaccine after positive Phase 3 topline results, with traders focused on the detailed data presentation at ESMO. Bulls see validation of a broader cancer-vaccine platform and momentum, while bears argue expectations and valuation are stretched and warn of a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Traders are citing a reported ClinicalTrials.gov update adding a site to Sareptas ENHANCE Elevidys safety study as a possible trigger for the rebound, though they note the study timeline reportedly slipped. The broader debate centers on whether upcoming DM1 and FSHD data can support a recovery, with some traders pointing to short covering and others stressing that those clinical results remain unproven.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and higher outlook have been met with a sharp selloff, prompting traders to question why strong demand and orders are not lifting the shares. The debate centers on rising costs, weaker cash conversion and an insurance loss, while some investors view the reaction as excessive given the improved guidance.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after its quarterly earnings beat and improved cash-flow outlook failed to prevent a sharp selloff, as traders focused on narrowed full-year profit guidance with no increase to its midpoint. Some see the new buyback and cash generation as support for the shares, while others argue the outlook disappointed despite the strong quarter.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash proceeds as a potential balance-sheet and strategic reset. Others argue the divestiture removes a significant revenue stream and leaves concerns about debt and weakness in the remaining business; the transaction is still pending approval and closing.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A sharp COMP rally has sparked breakout talk, with traders pointing to rising momentum, chart patterns, and the tokens limited supply; others remain skeptical, calling it a volatile bounce and questioning whether gains can hold.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

RAP-219s Phase 2 trial in bipolar mania met its primary and secondary endpoints, prompting bullish trading and analyst optimism, including an upgrade. The community is divided over the modest placebo-adjusted benefit and concerns about agitation and discontinuations; the initial surge faded as traders debated whether the data justify further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Will Dry Bulk Market Strength Lead EuroDry Stock to Higher Highs?

EDRY is riding stronger dry-bulk rates, with TCE more than doubling and profits rebounding as index-linked charters lift revenue exposure.

Futures Rise On Fresh Push Higher In Tech

Futures Rise On Fresh Push Higher In Tech

 Futures are higher again, just a few basis points away from a new all time high, led by Tech as the week starts with Semis / Memory / AI themes bid globally, as small-caps are fractionally in the red. As of 8:00am ET, S&P futures are 0.1...

Is Genco Shipping & Trading Limited (GNK) Outperforming Other Transportation Stocks This Year?

Here is how Genco Shipping & Trading (GNK) and Kirby (KEX) have performed compared to their sector so far this year.

Genco Shipping & Trading (GNK) Q2 Earnings and Revenues Surpass Estimates

Genco Shipping (GNK) delivered earnings and revenue surprises of +27.45% and +6.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks Industry Outlook International Seaways, Genko and ZIM 

Seaways, Genko and ZIM have been highlighted in this Industry Outlook article.

3 Shipping Stocks to Bet on Now as Industry Shows Promise

Following a careful analysis of the Zacks Transportation Shipping industry, we advise buying stocks like INSW, GNK and ZIM.

A.P. Moller-Maersk (AMKBY) Earnings Expected to Grow: Should You Buy?

A.P. Moller-Maersk (AMKBY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Genco Shipping & Trading (GNK) Earnings Expected to Grow: Should You Buy?

Genco Shipping (GNK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are You Looking for a Top Momentum Pick? Why Genco Shipping & Trading (GNK) is a Great Choice

Does Genco Shipping & Trading (GNK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Best Momentum Stocks to Buy for July 23rd

PLGO, BLDP and GNK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 23, 2026. 

Genco Shipping & Trading Ltd. is an international ship owning company, which engages in the transportation of iron ore, coal, grain, bauxite, steel products, and other drybulk cargoes. It operates through the Major Bulk and Minor Bulk segments. The Major Bulk segment focuses on Capesize vessels. The Minor Bulk segment consists of Ultramax and Supramax vessels. The company was founded on September 27, 2004 and is headquartered in New York, NY.

Genco Shipping & Trading Limited

Why Is DSX Stock Falling Today?

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>The new offer represents a 39% premium to Genco’s closing price as of late November last year, when Diana initially made the buyout offer.</li><li>Diana Shipping said its latest offer is fully financed with no underlying conditions, and the company has $1.433 billion in fully committed financing.</li><li>The firm has also nominated six independent candidates to Genco’s board.</li></ul><p>Shares of Diana Shipping Inc. (DSX) sank on Wednesday after the company raised its buyout offer for Genco Shipping &amp; Trading (GNK), as it continues to push for consolidation in the dry bulk carrier sector.</p><p>At the time of writing, DSX stock was down more than 6%.</p><h1 class="st-heading-1"><strong>DSX’s New Offer</strong></h1><p>Diana said it has raised its offer for Genco to $24.80 per share in cash, up from $23.50 per share in cash, representing a 39% premium to Genco’s closing price as of late November last year, when Diana Shipping initially made the buyout offer.</p><p>“Before Diana's involvement, Genco traded at an average 30% discount to NAV since 2020. As such, Genco shareholders face significant downside risk in the absence of Diana's offer. If the offer is not completed, Genco's share price could decline to approximately $18.00 per share if the stock reverts toward its historical trading,” Diana stated.</p><p>Diana Shipping said its latest offer is fully financed with no underlying conditions, and the company has $1.433 billion in fully committed financing from various leading European banks.</p><h1 class="st-heading-1"><strong>DSX’s Director Nominations</strong></h1><p>Additionally, Diana Shipping has nominated six independent candidates for election to Genco’s board as a contingency if the transaction fails to materialize. Notably, Diana Shipping is the largest single stakeholder in Genco, owning about 14.4% of its outstanding common stock.</p><p>“Our previous offers have each been met with silence, and we are hopeful that the Genco Board will finally sit down with us to engage in a constructive dialogue. This is the path forward that we strongly prefer, but we have also given Genco shareholders the opportunity to vote for our Board nominees – who we are confident will explore all opportunities to maximize value – and to tender their shares,” said Diana CEO Semiramis Paliou.</p><h1 class="st-heading-1"><strong>What Retail Thinks About DSX</strong></h1><p>On Stocktwits, retail sentiment about DSX turned ‘extremely bullish’ from ‘neutral’ over the last 24 hours.</p><p><a href="https://stocktwits.com/symbol/DSX">DSX stock</a> is up more than 69%, while GNK is up 28% so far this year, outperforming the benchmark S&amp;P Index.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

A Marshall Islands-registered "DIANA SHIPING" is docked for unloading at Rugao Port in Rugao City, Jiangsu province, China. (Photo credit should read CFOTO/Future Publishing via Getty Images)

Shares of Diana Shipping Inc. (DSX) sank on Wednesday after the company raised its buyout offer for Genco Shipping &amp; Trading (GNK), as it continues to push for consolidation in the dry bulk carrier sector.

Diana Shipping has raised its buyout offer for Genco to $24.80 per share in cash, up from $23.50 per share.

Diana Shipping Inc

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$24.73
Prev Close	$24.46
Open	$24.42
Dividend Yield	4.07%
50-Day Moving Average	$26.52
Beta	0.84
Avg. Volume	652,249.05
PE Ratio	26.95

52-Week High	$28.42
52-Week Low	$15.56
Market Capitalization	$1.07B
EPS (Annual)	-$0.1007
Price to Book	1.20
Revenue Per Employee	$348,678.90

Feed

News

Sentiment

Earnings

Fundamentals

Info

GNK Fundamentals